What Could Organoids Do For Your Research?
Register Now
Organoids are Revolutionizing In Vitro Cell Culture.
What Could They Do for Your Research?
Wednesday, 22 August 2018
10 AM PST | 1 PM EST | 5 PM UTC
Since landmark publications on intestinal and cerebral organoids, "mini-organs" have seen rapid adoption across many research areas and applications. Direct relevance to the tissue being modeled combined coupled with a great amenability to manipulation have demonstrated organoids as versatile model systems. Although organoids have been revolutionary in enabling experimentation in a more directly relevant system, the novelty of these systems and subtle differences between them can make it unclear where to start.
Register now to submit your question for our expert panel and join us on the day of the event to hear their answers.
Prior to joining STEMCELL Technologies in 2012, Dr. Conder investigated the mechanisms regulating proliferation and differentiation of adult intestinal stem cells in the group of Dr Jürgen Knoblich. Ryan is now a Senior Scientist and Team Lead of STEMCELL's Intestinal Team, responsible for products relating to intestinal organoid culture.
Prior to joining STEMCELL, Dr. Stingl led the Cancer Research UK Cambridge Institute's mammary stem cell research group. With over 30 publications to his name in journals such as Cell Stem Cell and Nature, John relocated back to Vancouver in 2016. John is currently Associate Director of the Epithelial Team at STEMCELL Technologies, overseeing the development of epithelial cell culture products.
Leon started at STEMCELL in 2014 after completing his studies on the structural biology of proteins involved in the autophagy pathway. Joining STEMCELL's Neural Team, Leon began working on human pluripotent stem cell (hPSC) differentiation to neural lineages, and since 2016 has led the development of hPSC-derived cerebral organoid products.
After graduating with his PhD in Biology, Dr. Kramer completed postdoctoral fellowships at the University of Texas' Center for Stem Cell and Regenerative Medicine and at the Wellcome Trust Centre for Human Genetics at the University of Oxford. In 2016, Philipp joined the Intestinal Team at STEMCELL Technologies, leading the development of STEMdiff™ products for directed differentiation of hPSCs into intestinal and renal organoids.
